Cerity Partners
BIVIW

Cerity Partners’s BioVie Inc Warrant BIVIW Stock Holding History

Cerity Partners’s Portfolio BIVIW Stock Details BIVIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,112
Closed -$5.45K – 3416
2025
Q4 		$5.45K Buy
20,112
+11
+0.1% +$4 ﹤0.01% 2870
2025
Q3 		$8.28K Buy
+20,101
New +$8.18K ﹤0.01% 2736

Other funds holding BIVIW

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Cerity Partners's BIVIW Position: Q1 2026 in Review

Cerity Partners sold out of BioVie Inc Warrant (BIVIW) in Q1 2026, closing a stake of 20,112 shares — an estimated $5.45K sold.

Cerity Partners first reported a position in BIVIW in Q3 2025 and held it in 2 quarters. The position peaked at $8.28K in Q3 2025. 8 funds tracked by Wall St. Rank hold BIVIW as of Q1 2026.

  • Cerity Partners reported no remaining BioVie Inc Warrant position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 20,112 BioVie Inc Warrant shares in Q1 2026, an estimated $5.45K.
  • Cerity Partners first reported a position in BioVie Inc Warrant in Q3 2025 and held it in 2 quarters.
  • Cerity Partners's BioVie Inc Warrant position peaked at $8.28K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.